Effective and lesion-free cutaneous influenza vaccination

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 16, 2015, Pages 5005-5010

  Wang, Ji ^a   Li, Bo ^a   Wu, Mei X ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biodegradable microneedle; dsDNA; Nonablative fractional laser

Indexed keywords

DOUBLE STRANDED DNA; INFLAMMASOME; INFLUENZA VACCINE; TOLL LIKE RECEPTOR; DNA; IMMUNOLOGICAL ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMORAL IMMUNITY; INFLAMMATION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LASER; LOW LEVEL LASER THERAPY; MICRONEEDLE; MOUSE; NONABLATIVE FRACTIONAL LASER; NONHUMAN; PIG; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN CELL; SKIN IRRITATION; VIRUS IMMUNITY; VIRUS STRAIN; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; CROSS PROTECTION; DRUG EFFECTS; IMMUNITY; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; NEEDLE; PATHOLOGY; REPRODUCIBILITY; SKIN; VACCINATION;

ANIMALIA; MUS; SUIDAE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; CROSS PROTECTION; DNA; IMMUNITY; INFLAMMATION; INFLUENZA VACCINES; INJECTIONS, INTRADERMAL; LASERS; MICE, INBRED BALB C; NEEDLES; REPRODUCIBILITY OF RESULTS; SKIN; SUS SCROFA; VACCINATION;

EID: 84928243612     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1500408112     Document Type: Article

References (43)

1. Karande P, Mitragotri S (2010) Transcutaneous immunization: An overview of advantages, disease targets, vaccines, and delivery technologies. Annu Rev Chem Biomol Eng 1:175-201.
2. Kim YC, Prausnitz MR (2011) Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res 1(1):7-12.
3. Chen X, Wu MX (2011) Laser vaccine adjuvant for cutaneous immunization. Expert Rev Vaccines 10(10):1397-1403.
4. Chen X, Pravetoni M, Bhayana B, Pentel PR, Wu MX (2012) High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine 31(1):159-164.
5. Wang J, Shah D, Chen X, Anderson RR, Wu MX (2014) A micro-sterile inflammation array as an adjuvant for influenza vaccines. Nat Commun 5:4447.
6. Depelsenaire AC, et al. (2014) Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol 134(9):2361-2370.
7. Chen X, Wang J, Shah D, Wu MX (2013) An update on the use of laser technology in skin vaccination. Expert Rev Vaccines 12(11):1313-1323.
8. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR (2004) Fractional photothermolysis: A new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 34(5):426-438.
9. Zehrung D, Jarrahian C, Wales A (2013) Intradermal delivery for vaccine dose sparing: overview of current issues. Vaccine 31(34):3392-3395.
10. Hickling JK, et al. (2011) Intradermal delivery of vaccines: potential benefits and current challenges. Bull World Health Organ 89(3):221-226.
11. Hickling J, Jones R, PATH, World Health Organization (2009) Intradermal Delivery of Vaccines: A Review of the Literature and the Potential for Development for use in Low- and Middle-Income Countries (PATH, Seattle).
12. Prow TW, et al. (2010) Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small 6(16):1776-1784.
13. Bachy V, et al. (2013) Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci USA 110(8):3041-3046.
14. Sullivan SP, et al. (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16(8):915-920.
15. Kim YC, Park JH, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64(14):1547-1568.
16. Yang SY, et al. (2013) A bio-inspired swellable microneedle adhesive for mechanical interlocking with tissue. Nat Commun 4:1702.
17. Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3):179-190.
18. Chen X, Kositratna G, Zhou C, Manstein D, Wu MX (2014) Micro-fractional epidermal powder delivery for improved skin vaccination. J Control Release 192:310-316.
19. Chen X, et al. (2010) A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS ONE 5(10):e13776.
20. Chen X, et al. (2012) Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology. J Control Release 159(1):43-51.
21. Lande R, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449(7162):564-569.
22. Marichal T, et al. (2011) DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 17(8):996-1002.
23. Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461-488.
24. Beran J, et al. (2009) Intradermal influenza vaccination of healthy adults using a new microinjection system: A 3-year randomised controlled safety and immunogenicity trial. BMC Med 7:13-7015-7-13.
25. Leroux-Roels I, et al. (2008) Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults. Vaccine 26(51):6614-6619.
26. Hutchison S, et al. (2012) Antigen depot is not required for alum adjuvanticity. FASEB J 26(3):1272-1279.
27. Vrdoljak A (2013) Review of recent literature on microneedle vaccine delivery technologies. Vaccine Dev Therapy 3:47-55.
28. Gill HS, Denson DD, Burris BA, Prausnitz MR (2008) Effect of microneedle design on pain in human volunteers. Clin J Pain 24(7):585-594.
29. Kochhar JS, et al. (2013) Effect of microneedle geometry and supporting substrate on microneedle array penetration into skin. J Pharm Sci 102(11):4100-4108.
30. Yan G, Warner KS, Zhang J, Sharma S, Gale BK (2010) Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm 391(1-2):7-12.
31. Hancock K, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361(20):1945-1952.
32. Skowronski DM, et al. (2014) Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS ONE 9(3):e92153.
33. Chamilos G, et al. (2012) Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood 120(18):3699-3707.
34. Sørensen OE, et al. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170(11):5583-5589.
35. Ishikawa H, Ma Z, Barber GN (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461(7265):788-792.
36. Paludan SR, Bowie AG (2013) Immune sensing of DNA. Immunity 38(5):870-880.
37. Wu J, et al. (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339(6121):826-830.
38. Sun L, Wu J, Du F, Chen X, Chen ZJ (2013) Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339(6121):786-791.
39. McKee AS, et al. (2013) Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells. Proc Natl Acad Sci USA 110(12):E1122-E1131.
40. Woo SR, et al. (2014) STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41(5):830-842.
41. Gregorio J, et al. (2010) Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med 207(13):2921-2930.
42. Lande R, et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3(73):73ra19.
43. Rani M, Zhang Q, Schwacha MG (2014) Burn wound γδ T-cells support a Th2 and Th17 immune response. J Burn Care Res 35(1):46-53.